Weiping Liu Selected Research

Weiping Liu Research Topics

Disease

58	Neoplasms (Cancer) 05/2024 - 08/2002
14	Lymphoma (Lymphomas) 12/2023 - 08/2002
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 12/2013
12	Breast Neoplasms (Breast Cancer) 01/2020 - 09/2007
11	Infections 02/2024 - 06/2007
9	T-Cell Lymphoma (Lymphoma, T Cell) 01/2024 - 08/2002
9	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2014
7	Hodgkin Disease (Hodgkin's Disease) 03/2024 - 04/2014
7	Disease Progression 10/2023 - 12/2014
7	Multiple Myeloma 10/2023 - 05/2019
7	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2007
7	Glioma (Gliomas) 01/2021 - 12/2007
6	Extranodal NK-T-Cell Lymphoma 01/2024 - 07/2013
6	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2024 - 01/2018
5	Carcinogenesis 01/2023 - 06/2013
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2018
5	Carcinoma (Carcinomatosis) 05/2022 - 07/2003
5	Cognitive Dysfunction 09/2021 - 01/2018
5	Epilepsy (Aura) 01/2021 - 01/2013
5	Primary Ovarian Insufficiency 01/2021 - 01/2018
4	Birth Weight (Birth Weights) 11/2023 - 02/2017
4	COVID-19 01/2022 - 01/2020
4	Inflammation (Inflammations) 01/2021 - 03/2015
3	Pituitary Neoplasms (Pituitary Adenoma) 01/2023 - 08/2005
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2014
3	Lymphatic Metastasis 01/2021 - 01/2014
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 07/2017
3	Body Weight (Weight, Body) 08/2020 - 02/2008
3	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019 - 11/2014
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2018 - 04/2015
3	Hypoxia (Hypoxemia) 06/2018 - 01/2013
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018 - 08/2002
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016 - 10/2010
3	Adenocarcinoma 01/2015 - 01/2014
3	Colorectal Neoplasms (Colorectal Cancer) 08/2014 - 01/2014
3	Type 2 Diabetes Mellitus (MODY) 01/2014 - 10/2007
2	Hepatitis B 02/2024 - 12/2023
2	Nervous System Diseases (Neurological Disorders) 01/2024 - 01/2021
2	Neutropenia 10/2023 - 02/2017
2	Sepsis (Septicemia) 10/2023 - 07/2020
2	Liver Neoplasms (Liver Cancer) 01/2023 - 03/2016
2	Monoclonal Gammopathy of Undetermined Significance 01/2022 - 05/2019
2	Pain (Aches) 06/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2007
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2005
7	Messenger RNA (mRNA)IBA 01/2022 - 08/2005
6	Vincristine (Oncovin)FDA LinkGeneric 12/2022 - 07/2012
6	Asparaginase (Elspar)FDA Link 09/2022 - 07/2012
6	EnzymesIBA 01/2022 - 09/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 11/2014
5	RNA (Ribonucleic Acid)IBA 12/2023 - 12/2014
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 07/2013
5	Rituximab (Mabthera)FDA Link 12/2022 - 04/2013
5	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022 - 01/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 11/2019
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 01/2012
4	CytokinesIBA 01/2024 - 01/2017
4	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2019
4	Prednisone (Sone)FDA LinkGeneric 12/2022 - 07/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 07/2013
4	CateninsIBA 04/2022 - 01/2014
4	AntioxidantsIBA 01/2021 - 12/2007
4	Immunoglobulins (Immunoglobulin)IBA 05/2019 - 01/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 07/2013
4	DDTIBA 02/2017 - 01/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 05/2022
3	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 06/2006
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2024 - 09/2015
3	daratumumabIBA 10/2023 - 01/2021
3	liposomal doxorubicin (Doxil)FDA Link 12/2022 - 01/2021
3	SoilIBA 01/2022 - 12/2014
3	Immunoglobulin M (IgM)IBA 01/2022 - 12/2014
3	ImmunosorbentsIBA 01/2022 - 09/2007
3	Hormones (Hormone)IBA 01/2022 - 01/2019
3	Anaplastic Lymphoma KinaseIBA 01/2021 - 07/2017
3	HMGB1 Protein (HMG1)IBA 10/2019 - 01/2018
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019 - 11/2014
3	Superoxide DismutaseIBA 01/2017 - 01/2002
3	Dichlorodiphenyl Dichloroethylene (DDE)IBA 03/2016 - 01/2014
3	PlatinumIBA 05/2015 - 10/2008
2	Gemcitabine FDA Link 03/2024 - 12/2014
2	Circulating Tumor DNAIBA 01/2024 - 01/2022
2	Bortezomib (Velcade)FDA Link 01/2023 - 01/2021
2	ProdrugsIBA 01/2023 - 05/2022
2	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2022
2	AnthracyclinesIBA 09/2022 - 01/2021
2	Everolimus FDA Link 07/2022 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 01/2013
2	pegaspargase (Oncaspar)FDA Link 01/2022 - 02/2017
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2022 - 02/2021
2	Surface Antigens (Surface Antigen)IBA 01/2022 - 09/2015
2	CollagenIBA 08/2021 - 03/2019
2	Nucleic AcidsIBA 02/2021 - 12/2020

Therapy/Procedure

30	Therapeutics 03/2024 - 01/2007
19	Drug Therapy (Chemotherapy) 12/2023 - 07/2012
7	Hematopoietic Stem Cell Transplantation 11/2023 - 02/2019
6	Stem Cell Transplantation 01/2024 - 07/2017
6	Radiotherapy 01/2022 - 07/2012
4	Transplantation 05/2018 - 10/2011
2	Immunotherapy 02/2021 - 08/2019